All Stories

  1. A Standardized M3Cs clinical validity framework for microRNA data in microRNA databases with application to MicroRNA Childhood Cancer Catalog (M3Cs) version 2.0

    Article • May 2024, Research Square

    Dr Wafaa M. Rashed

  2. ASSESSMENT OF POSTURAL STABILITY IN CHILDREN WITH POSTERIOR FOSSA TUMOR

    Article • January 2024, Authorea, Inc.

    Mahmoud Usama, Dr Wafaa M. Rashed

  3. Coronavirus Disease 2019 (COVID-19) Pandemic across Africa: Current Status of Vaccinations and Implications for the Future

    Article • Vaccines, September 2022, MDPI AG

    Dr Wafaa M. Rashed

  4. Germline De Novo Mutations as a Cause of Childhood Cancer

    Article • JCO Precision Oncology, July 2022, American Society of Clinical Oncology (ASCO)

    Dr Wafaa M. Rashed

  5. Infant Feeding Practices And Childhood Acute Leukemia: Findings From The Childhood Cancer & Leukemia International Consortium

    Article • International Journal of Cancer, May 2022, Wiley

    Dr Wafaa M. Rashed

  6. MicroRNA childhood cancer catalog (M3Cs): a resource for translational bioinformatics toward health informatics in pediatric cancer

    Article • Database, January 2022, Oxford University Press (OUP)

    Dr Wafaa M. Rashed

  7. Immunotherapy for Pediatric Cancer

    Article • January 2022, Springer Science + Business Media

    Dr Wafaa M. Rashed

  8. MicroRNA childhood Cancer Catalog (M3Cs): A Resource for Translational Bioinformatics Toward Health Informatics in Pediatric Cancer

    Article • July 2021, Cold Spring Harbor Laboratory Press

    Dr Wafaa M. Rashed

  9. mRNA-miRNA-lncRNA Regulatory Network in Nonalcoholic Fatty Liver Disease

    Article • International Journal of Molecular Sciences, June 2021, MDPI AG

    Dr Wafaa M. Rashed

  10. Current HCC Clinical and Research in Egypt

    Article • January 2021, Springer Science + Business Media

    Dr Wafaa M. Rashed

  11. Reduced-intensity therapy of pediatric lymphoblastic leukemia: Impact of residual disease early in remission induction

    Article • Blood, October 2020, American Society of Hematology

    Dr Wafaa M. Rashed

  12. MET canonical transcript expression is a predictive biomarker for chemo-sensitivity to MET-inhibitors in hepatocellular carcinoma cell lines

    Article • Journal of Cancer Research and Clinical Oncology, September 2020, Springer Science + Business Media

    Dr Wafaa M. Rashed

  13. Response to the Novel Corona Virus (COVID-19) Pandemic Across Africa: Successes, Challenges, and Implications for the Future

    Article • Frontiers in Pharmacology, September 2020, Frontiers

    Amanj Kurdi, Dr Wafaa M. Rashed

  14. The outcome of childhood adrenocortical carcinoma in Egypt: A model from developing countries

    Article • Pediatric Hematology and Oncology, January 2020, Taylor & Francis

    Dr Wafaa M. Rashed, Dr Ahmed Samir Alfaar

  15. Hepatocellular Carcinoma (HCC) in Egypt: A comprehensive overview

    Article • Journal of the Egyptian National Cancer Institute, January 2020, Springer Science + Business Media

    Dr Wafaa M. Rashed

  16. MicroRNA as a prognostic biomarker for survival in childhood acute lymphoblastic leukemia: a systematic review

    Article • Cancer and Metastasis Reviews, December 2019, Springer Science + Business Media

    Dr Wafaa M. Rashed

  17. Pediatric diffuse intrinsic pontine glioma: where do we stand?

    Article • Cancer and Metastasis Reviews, December 2019, Springer Science + Business Media

    Dr Wafaa M. Rashed, Prof Mohamed Saad Zaghloul

  18. MicroRNA as a diagnostic biomarker in childhood acute lymphoblastic leukemia; systematic review, meta-analysis and recommendations

    Article • Critical Reviews in Oncology/Hematology, April 2019, Elsevier

    Dr Wafaa M. Rashed

  19. C-MET as a potential target therapy toward personalized therapy in some pediatric tumors: An overview

    Article • Critical Reviews in Oncology/Hematology, November 2018, Elsevier

    Dr Wafaa M. Rashed

  20. Incidence of adrenal gland tumor as a second primary malignancy: SEER-based study

    Article • Endocrine Connections, August 2018, Bioscientifica

    Dr anas M. saad, Dr Ahmed Samir Alfaar, Dr Wafaa M. Rashed

  21. Advanced parental age as risk factor for childhood acute lymphoblastic leukemia: results from studies of the Childhood Leukemia International Consortium

    Article • European Journal of Epidemiology, May 2018, Springer Science + Business Media

    Dr Wafaa M. Rashed

  22. Risk of second malignancies among survivors of pediatric thyroid cancer

    Article • International Journal of Clinical Oncology, February 2018, Springer Science + Business Media

    Dr Wafaa M. Rashed, Dr Ahmed Samir Alfaar

  23. 467PIncidence of adrenal gland tumor as a second primary malignancy: SEER based database

    Article • Annals of Oncology, September 2017, Oxford University Press (OUP)

    Dr anas M. saad, Dr Wafaa M. Rashed

  24. Nonfunctioning Adrenocortical Carcinoma in Pediatric Acute Lymphoblastic Leukemia

    Article • Journal of Pediatric Hematology/Oncology, March 2017, Wolters Kluwer Health

    Dr Ahmed Samir Alfaar, Dr Wafaa M. Rashed

  25. Patients’ guardians, Practitioners and Population (3Ps) opinions in pediatric oncology clinical trials in developing country: a cross-sectional survey

    Article • European Journal of Cancer, February 2017, Elsevier

    Dr Wafaa M. Rashed

  26. Environmental, maternal, and reproductive risk factors for childhood acute lymphoblastic leukemia in Egypt: a case-control study

    Article • BMC Cancer, August 2016, Springer Science + Business Media

    Dr Wafaa M. Rashed

  27. A change roadmap towards research paradigm in low-resource countries: retinoblastoma model in Egypt

    Article • International Ophthalmology, April 2016, Springer Science + Business Media

    Dr Ahmed Samir Alfaar, Dr Wafaa M. Rashed

  28. Caesarean delivery and risk of childhood leukaemia: a pooled analysis from the Childhood Leukemia International Consortium (CLIC)

    Article • The Lancet Haematology, April 2016, Elsevier

    Dr Wafaa M. Rashed, Laurent Orsi

  29. Abstract B07: Prevalence of the most common fusion gene transcripts in 1080 Egyptian pediatric acute lymphoblastic leukemia patients: Children Cancer Hospital Egypt (CCHE) experience.

    Article • Clinical Cancer Research, August 2015, American Association for Cancer Research (AACR)

    Dr Wafaa M. Rashed

  30. Abstract LB-194: Cesarean delivery and risk of childhood leukemia: findings from the Childhood Leukemia International Consortium (CLIC):

    Article • Cancer Research, August 2015, American Association for Cancer Research (AACR)

    Dr Wafaa M. Rashed

  31. Maternal Supplementation with Folic Acid and Other Vitamins and Risk of Leukemia in Offspring

    Article • Epidemiology, November 2014, Wolters Kluwer Health

    Dr Wafaa M. Rashed

  32. 46thCongress of the International Society of Paediatric Oncology (SIOP) 2014

    Article • Pediatric Blood & Cancer, October 2014, Wiley

    Dr Wafaa M. Rashed

  33. 1084PESTABLISHING CLINICAL RESEARCH IN A LIMITED RESOURCE SETTING, "ACUTE LYMPHOBLASTIC LEUKEMIA MODEL"

    Article • Annals of Oncology, September 2014, Oxford University Press (OUP)

    Dr Wafaa M. Rashed

  34. High-dose methotrexate in Egyptian pediatric acute lymphoblastic leukemia: the impact of ABCG2 C421A genetic polymorphism on plasma levels, what is next?

    Article • Journal of Cancer Research and Clinical Oncology, April 2014, Springer Science + Business Media

    Dr Wafaa M. Rashed

  35. Abstract LB-31: Maternal supplementation with folic acid and other vitamins before and during pregnancy and risk of leukemia in the offspring: A childhood leukemia international consortium (CLIC) study.

    Article • Cancer Research, April 2013, American Association for Cancer Research (AACR)

    Dr Wafaa M. Rashed

  36. 44thCongress of the International Society of Paediatric Oncology (SIOP) 2012, London, United Kingdom, 5th-8thOctober, 2012 SIOP abstracts

    Article • Pediatric Blood & Cancer, September 2012, Wiley

    Dr Wafaa M. Rashed

  37. 1144 Risk Factors for TEL-AML Fusion Gene and Childhood Acute Lymphoblastic Leukemia in Egypt

    Article • European Journal of Cancer, July 2012, Elsevier

    Dr Wafaa M. Rashed

  38. 780 Effect of Breast Cancer Resistance Protein (BCRB) (C421A) Genetic Polymorphism on the Induction Response in the Treatment of Egyptian Pediatric Acute Lymphoblastic Leukemia, Children's Cancer Hospital Egypt-(CCHE)-57357 Experience

    Article • European Journal of Cancer, July 2012, Elsevier

    Dr Wafaa M. Rashed